ArticleData Protection Post-Brexit – Deal Or No Deal?The UK Government has produced a series of technical notices explaining what businesses might need to do if there is a "no deal" Brexit.United KingdomPrivacyRopes & Gray LLP
ArticleFive Takeaways From Private Equity Chicago Forum 2024We attended this year's Private Equity Chicago Forum, joining more than 300 industry leaders from LPs, GPs and advisory firms to explore opportunity in the global and U.S. private equity markets. Debbie Gersh...United StatesCorporate/Commercial LawRopes & Gray LLP
ArticleDepartment Of Labor Releases Final 18-Month Delay In Applicability Date For Portions Of Fiduciary RuleOn November 29, 2017, the U.S. Department of Labor (the "DOL") published final amendments to the Best Interest Contract Exemption and other exemptions that delay the applicability date...United StatesEmployment and HRRopes & Gray LLP
ArticleMandatory Overtime Restrictions For Nurses Approaching; Massachusetts Nurses Association Issues Its Own Guidance To NursesAs we reported in August, restrictions on the use of mandatory overtime for nurses in a hospital setting will go into effect on November 4, 2012.United StatesEmployment and HRRopes & Gray LLP
ArticleSupreme Court Agrees To Hear Intel Case With Potentially Significant Implications For 401(k) Plan FiduciariesOn June 10, 2019, the U.S. Supreme Court agreed to hear Intel Corp. Investment Policy Committee et al. v. Sulyma, and the outcome of this decision may have major ramifications for 401(k) investment menu design.United StatesEmployment and HRRopes & Gray LLP
ArticleChina Unveils Detailed Rules to Implement The Core Device RegulationThe amended Regulation for the Supervision and Administration of Medical Devices (the "Regulation," also known as the State Council Order No. 650), which came into force on June 1, 2014, set the new framework for China’s device regulatory regime. United StatesFood, Drugs, Healthcare, Life SciencesRopes & Gray LLP
ArticlePTAB Oral Advocacy Webinar TodayEarlier this year, the USPTO launched the Patent Trial and Appeal Board's (PTAB) Legal Experience and Advancement Program (LEAP). LEAP is designed to foster development of the next generation of patent practitioners by creating ...United StatesIntellectual PropertyRopes & Gray LLP
ArticleInternational Trade Commission Settles Open Question On Filing Of Third-Party Settlement Agreements When Terminating InvestigationsIn a typical federal district court litigation, parties need not disclose to the court the terms of a settlement agreement. Not so in Section 337 investigations before the U.S. International...United StatesInternational LawRopes & Gray LLP
ArticleStates Bet On Sports Wagering To Fill State Coffers After Supreme Court DecisionThe Supreme Court was presented with a challenge to the state of New Jersey's attempts to repeal prior states laws prohibiting sports wagering.United StatesMedia, Telecoms, IT, EntertainmentRopes & Gray LLP
ArticleSEC Issues Cyber Incident Disclosure GuidanceOn October 13, 2011, the United States Securities and Exchange Commission released guidance from the Division of Corporation Finance (Division) addressing the appropriate disclosure of cybersecurity risks and cyber incidents. United StatesPrivacyRopes & Gray LLP
ArticleCompensation And Unrelated Business Income Are Focus Of IRS Colleges And Universities ReportThe IRS report is based on audits of a relatively small group of colleges and universities specifically targeted by the IRS for potential noncompliance issues, and the report makes clear that assumptions about other colleges and universities should not be drawn based on the report.United StatesTaxRopes & Gray LLP
ArticleControversy Brewing Over Massachusetts Taxation Of NonresidentsThe Massachusetts Department of Revenue promulgated on July 21, 2020 an emergency regulation to address income-sourcing concerns during the COVID-19 pandemic.United StatesTaxRopes & Gray LLP
ArticleChina Proposes Major Changes To Pharmaceutical RegulationsOn April 20, 2019, the Chinese government submitted a second draft of the Drug Administration Law of the People's Republic of China to the Standing Committee of the NPC for deliberation. ChinaFood, Drugs, Healthcare, Life SciencesRopes & Gray LLP
ArticleReflections For Dealmakers From JPMorgan Healthcare Conference 2023As everyone unpacks from last week's JPMorgan Healthcare Conference 2023 and digests their various meetings, it is worth reflecting on some of the key themes to emerge.United KingdomIntellectual PropertyRopes & Gray
ArticleRopes & Gray's Investment Management Update December 2020–January 2021The SEC staff's no-action assurances were based upon the funds' representations and subject to a number of conditions, described in the incoming letter and summarized below.United StatesFinance and BankingRopes & Gray LLP
ArticleSupreme Court Upholds Regulatory Time Limitations On PRRB AppealsOn January 22, 2013, the United States Supreme Court unanimously upheld the Secretary of HHS’s regulation establishing an absolute three-year limit for taking an appeal from a Notice of Provider Reimbursement ("NPR"). United StatesFood, Drugs, Healthcare, Life SciencesRopes & Gray LLP
ArticleIntellectual Property Legislation Update: The Trade Protection Not Troll Protection Act Of 2017The TPNTPA focuses on the U.S. International Trade Commission (ITC), a quasi-judicial federal agency in Washington, D.C. with broad investigative powers on matters of tradeUnited StatesIntellectual PropertyRopes & Gray LLP
ArticleAgents Provocateurs: Combating the Epidemic of Rogue AgentsIn recent months, the NCAA has launched several investigations into inappropriate relationships between student-athletes and agents or their runners. United StatesMedia, Telecoms, IT, EntertainmentRopes & Gray LLP
ArticleChina Announces Amendments to Regulation on the Supervision and Administration of Medical DevicesOn May 19, 2017, China's State Council promulgated the amendments to the 2014 Regulation on the Supervision and Administration of Medical Devices ("the Amendments"), which became effective immediately.ChinaFood, Drugs, Healthcare, Life SciencesRopes & Gray LLP
ArticleChina Solicits Comments On Biosimilars GuidelineThe Center for Drug Evaluation of the China Food and Drug Administration published a long-awaited guidance document for companies seeking to develop biosimilars.ChinaFood, Drugs, Healthcare, Life SciencesRopes & Gray LLP